News

Ipsen's Ojemda (Tovorafenib) Becomes First Targeted Therapy for Pediatric Brain Tumors in EU

Pediatric Oncology - Low-Grade Glioma · 3 min

Pharma 2026 EU: Key Takeaways from Day 1

general · 4 min

Pharma News: Purdue Sentencing, Supply Chain Woes, ASCO Previews

general · 4 min

SLAS Europe 2026: Lab Automation & Screening Innovations

general · 3 min

Pharma Partnering EU 2026: Biotech BD&L Trends to Watch

biotech · 4 min

Pharma Innovation in EU: Previewing Key Trends Beyond Global Pharma Tech

general · 4 min

ISCT 2026: Cell & Gene Therapy Manufacturing Innovations in Dublin

manufacturing · 4 min

RAPS Euro Convergence 2026: EU MDR & Regulatory Tech

regulatory · 4 min

European Research Revolution: Clinical Trial Tech Focus

general · 2 min

Swiss Biotech Day 2026: Previewing Key Biotech Trends

biotech · 3 min

EU BioPharma Clinical Trials: Key Oncology Data at ASCO & AUA

general · 3 min

Reuters Pharma 2024: Key Themes & Expert Speakers in Focus

general · 8 min